Yanping Wang, MD, received her medical degree at Norman Bethune University of Medical Science in China. She joined the Kim Laboratory in 2006. Her research focuses on immunotherapy for urologic cancer.
Shengchen Su, PhD, received her doctorate at Virginia Polytechnic Institute and State University. She joined the Kim Laboratory in 2018. Her research focuses on identifying and validating the predictive makers of angiogenesis inhibitor treatment for clear cell renal carcinoma.
Austin Yeon received his bachelor's of science in biology at the University of Southern California. He joined the Kim Laboratory in 2016. His research focuses on urological cancer immunology and immunotherapy.